MLH1 expression predicts the response to preoperative therapy and is associated with PD-L1 expression in esophageal cancer

Programmed death-ligand 1 (PD-1/PD-L1) inhibition therapy demonstrates potential as a future treatment for esophageal cancer. Mismatch repair status and tumor PD-L1 expression are the candidate predictive biomarkers for response to this therapy. In colorectal cancer, mismatch repair-deficient tumors...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Momose, Kota, Yamasaki, Makoto, Tanaka, Koji, Miyazaki, Yasuhiro, Makino, Tomoki, Takahashi, Tsuyoshi, Kurokawa, Yukinori, Nakajima, Kiyokazu, Takiguchi, Shuji, Mori, Masaki, Doki, Yuichiro
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2017
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494664/
https://ncbi.nlm.nih.gov/pubmed/28693258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6215
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky